JPRN-UMIN000042161已完成未知
The attenuating effect of HBF2020-02 on postprandial blood glucose levels in healthy human subjects -A placebo controlled, randomized, double blind, cross-over study- - The attenuating effect of HBF2020-02 on postprandial blood glucose levels in healthy human subjects
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •[1] Who use medical products affecting blood glucose. [2] Who can't stop using supplements and/or functional foods including "foods for specified health use" and/or "food with function claims" which affecting blood glucose level during the study period. [3] Who can't abstinent from alcohol from two days before each examination. [4] Who are allergic to placebo food and/or test food and/or the ingredient of high-carbohydrate diet. [5] Who are judged to be diagnosed with diabetes or carbohydrate metabolic disorders. [6] Who have a history of serious kidney damage, hepatopathy, heart disease, respiratory disease, endocrine disease, or any other metabolic disease(s) or who is under medical treatment. [7] Who have chronic disease and is under medication. [8] Who have digestive organ disease, surgical history affecting digestion and absorption of foods, or a disorder such as stenosis in the digestive tract. [9] Who are judged inappropriate for the study by the investigator. [10] Who are diagnosed as severe anemia in screening and not suitable for frequent collection of blood. [11] Who had an onset diarrhea within a week from the date of screening, and/or who are prone to diarrhea on a daily basis. [12] Who donated blood over 200mL in the past a month or over 400mL in the past 3 months from the date of informed consent. [13] Drug addict and/or alcohol addict. [14] Who are participating in other studies that using food(s), pharmaceutical(s), and cosmetic(s) now, or who have participated or are willing to participate in other studies within a month from the date of informed consent. [15] Who are or are possibly pregnant, or who are lactating, during the study period. [16] Who are judged inappropriate for the study by the investigator.
研究者
相似试验
已完成
不适用
The attenuating effect of HBF2019-03 on postprandial serum triglyceride level in healthy human subjects -A placebo controlled, randomized, double blind, cross-over study/A (healthy adults)JPRN-UMIN000038037KSO Corporation90
已完成
不适用
Evaluation of the effect of HBF2020-05 intake on visual function.Healthy Japanease adultsJPRN-UMIN000045803Hayashibara CO., LTD.32
已完成
不适用
Preliminary study on the protective effects of habitual intake of BLP on the colorectal tumorsColorectal tumor (adenoma, adenocarcinoma)JPRN-UMIN000025389Graduate School of Medical Science, Kyoto Prefectural University of Medicine30
尚未招募
不适用
A study to compare the effects of 0.5% Hyperbaric Bupivacaine and 0.5% Hyperbaric Levobupivacaine for Spinal Anaesthesia in Lower Abdominal SurgeryCTRI/2023/02/050134Dr Angana Nath
已完成
不适用
Increased inhibitory effect confirmation of postprandial glucose level by powder was wheat fermented with Bacillus.impaired glucose toleranceJPRN-UMIN000011343Mie University, Graduate School of Medicine13